Skip to main content
Clinical Trials/NCT05354479
NCT05354479
Unknown
Phase 4

Efficacy of Expressed Breast Milk Alone or in Combination With Paracetamol in Reducing Pain During ROP Screening

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh1 site in 1 country60 target enrollmentOctober 20, 2021
ConditionsPain Control
InterventionsParacetamol

Overview

Phase
Phase 4
Intervention
Paracetamol
Conditions
Pain Control
Sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Enrollment
60
Locations
1
Primary Endpoint
Decrease in pain
Last Updated
4 years ago

Overview

Brief Summary

Efficacy of Expressed Breast Milk Alone or in Combination with Paracetamol in Reducing Pain during ROP Screening.

Detailed Description

Retinopathy of prematurity (ROP) has been widely acknowledged to be the primary cause of preventable childhood blindness in developing countries. However, the procedure for screening is extremely painful. In this study, we will attempt to relieve the pain experienced by these babies using breast milk alone or in combination with oral paracetamol. This randomized control trial study will be conducted with the aim to assess the efficacy of Expressed Breast Milk Alone or in Combination with Paracetamol in Reducing Pain during ROP Screening. All preterm neonate who undergone ROP screening will be the study population. A total of 60 preterm neonates will be randomized into three groups: (Group A - control group = 20, Group B - breast milk group = 20, and Group C - oral paracetamol + breast milk = 20). Group A will get current care as per institutional protocol, Group B received 2 ml expressed breast milk (EBM) through a sterile syringe orally 2 min prior to procedure, Group C received syrup paracetamol, 15 mg/kg 30 min prior to procedure and EBM as in Group B. Pain experienced was measured by the premature infant pain profile (PIPP) score 20 s prior, during and 2 min after procedure. All procedures were video recorded. The Ophthalmologist and analyzer both will be blinded to the intervention. Results will be incorporated after enrollment

Registry
clinicaltrials.gov
Start Date
October 20, 2021
End Date
April 19, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Responsible Party
Principal Investigator
Principal Investigator

Rumpa Mani Chowdhury

DR

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Eligibility Criteria

Inclusion Criteria

  • Gestational age \<35 weeks, and birth weight \<2000 gm

Exclusion Criteria

  • Parents of neonate who refused to participate in the study
  • Newborns with multiple congenital anomalies
  • Patient who is on mechanical ventilator during ROP examination
  • Neonate receiving narcotic or sedative drugs
  • Neonate not receiving oral feed.

Arms & Interventions

Expressed breast milk

Babies will get only expressed breast milk.

Intervention: Paracetamol

paracetamol plus expressed breast milk

Babies will get expressed breast milk plus paracetamol

Intervention: Paracetamol

Outcomes

Primary Outcomes

Decrease in pain

Time Frame: 6 months

Premature Infant Pain Score

Study Sites (1)

Loading locations...

Similar Trials